Literature DB >> 12189383

Modulating T-cell immunity to tumours: new strategies for monitoring T-cell responses.

Cassian Yee1, Philip Greenberg.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12189383     DOI： 10.1038/nrc820

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN： 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  21 in total

1.  A multimodal targeting nanoparticle for selectively labeling T cells.

Authors:  Jonathan Gunn; Herschel Wallen; Omid Veiseh; Conroy Sun; Chen Fang; Jianhong Cao; Cassian Yee; Miqin Zhang
Journal:  Small       Date:  2008-06       Impact factor: 13.281

2.  Ultrasimple Single-Cell Detection of Multiple Cytokines by a Nanowell Chip Integrated with Encoded Microarrays.

Authors:  Mohammed A A Abdullah; Jun Wang
Journal:  ACS Sens       Date:  2019-09-06       Impact factor: 7.711

3.  Monitoring of vaccine-specific gamma interferon induction in genital mucosa of mice by real-time reverse transcription-PCR.

Authors:  Véronique Revaz; Anne Debonneville; Martine Bobst; Denise Nardelli-Haefliger
Journal:  Clin Vaccine Immunol       Date:  2008-03-26

Review 4.  Epigenetics: A primer for clinicians.

Authors:  Benjamin E Paluch; Abdul R Naqash; Zachary Brumberger; Michael J Nemeth; Elizabeth A Griffiths
Journal:  Blood Rev       Date:  2016-02-26       Impact factor: 8.250

5.  Developing effective tumor vaccines: basis, challenges and perspectives.

Authors:  Qingwen Xu; Weifeng Chen
Journal:  Front Med China       Date:  2007-02-01

6.  Tumor cells and memory T cells converge at glycolysis: therapeutic implications.

Authors:  Swathi Karthikeyan; Jean-Francois Geschwind; Shanmugasundaram Ganapathy-Kanniappan
Journal:  Cancer Biol Ther       Date:  2014-02-20       Impact factor: 4.742

7.  The innate immune system recognizes and regulates major histocompatibility complex class I (MHCI) expression on MHCIlow tumor cells.

Authors:  Bent Rubin; Joëlle Riond; Laetitia Courtiade; Nicolas Roullet; Jean-Edouard Gairin
Journal:  Cancer Immun       Date:  2008-09-11

8.  Adoptive transfer of Tc1 or Tc17 cells elicits antitumor immunity against established melanoma through distinct mechanisms.

Authors:  Yu Yu; Hyun-Ii Cho; Dapeng Wang; Kane Kaosaard; Claudio Anasetti; Esteban Celis; Xue-Zhong Yu
Journal:  J Immunol       Date:  2013-01-11       Impact factor: 5.422

9.  Autologous MUC1-specific Th1 effector cell immunotherapy induces differential levels of systemic TReg cell subpopulations that result in increased ovarian cancer patient survival.

Authors:  Mark J Dobrzanski; Kathleen A Rewers-Felkins; Imelda S Quinlin; Khaliquzzaman A Samad; Catherine A Phillips; William Robinson; David J Dobrzanski; Stephen E Wright
Journal:  Clin Immunol       Date:  2009-09-16       Impact factor: 3.969

10.  Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.

Authors:  Cedrik Michael Britten; Sylvia Janetzki; Leah Ben-Porat; Timothy M Clay; Michael Kalos; Holden Maecker; Kunle Odunsi; Michael Pride; Lloyd Old; Axel Hoos; Pedro Romero
Journal:  Cancer Immunol Immunother       Date:  2009-03-04       Impact factor: 6.968
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.